Delivery Order SPE2DB24D2212-SPE2DB25FHNBF
Award Date
10/24/24
Potential Completion Date
10/25/24
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,997.96 Firm Fixed Price Delivery Order has an ultimate completion date of January 11, 2024 and covers the supply of the medication MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,061.86 firm fixed-price delivery order contract is for the provision of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S medication. The contract has an ultimate completion date of August 7, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,008.50, is a Firm Fixed Price Delivery Order for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded on October 30, 2024, is a Firm Fixed Price Delivery Order valued at $1,180.74 with a completion date of October 31, 2024. The contract covers the procurement of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product, with no set-aside designation. AmerisourceBergen also holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,491.58 firm fixed-price delivery order is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a medication. The contract has a completion date of February 26, 2024 and was awarded on February 23, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a $3,217.50 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S medication. The contract has an ultimate completion date of May 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,107.65 firm fixed price delivery order contract is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a specialty pharmaceutical product. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,345.59, is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG tablets. It is a firm fixed-price delivery order contract that runs through April 1, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,530.90 firm fixed-price delivery order is for the medical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, with a final completion date of November 6, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FN2G5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,530.90 delivery order contract is for the medical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, with a completion date of May 1, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...